Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America
Author(s) -
Serena P. Koenig,
Ahra Kim,
Bryan E. Shepherd,
Carina César,
Valdiléa G. Veloso,
Claudia P. Cortés,
Denis Padgett,
Brenda CrabtreeRamírez,
Eduardo Gotuzzo,
Catherine C. McGowan,
Timothy R. Sterling,
Jean W. Pape
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz1032
Subject(s) - medicine , hazard ratio , tuberculosis , latin americans , human immunodeficiency virus (hiv) , confidence interval , demography , gerontology , pediatrics , immunology , pathology , linguistics , philosophy , sociology
We assessed the association between cured tuberculosis (TB) and mortality among persons living with human immunodeficiency virus (HIV) in Latin America. We compared survival among persons with and without TB at enrollment in HIV care, starting 9 months after clinic enrollment. In multivariable analysis, TB was associated with higher long-term mortality (hazard ratio, 1.57; 95% confidence interval, 1.25-1.99).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom